Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 89105-94-2
2. Chembl409436
3. Fibrinogen-binding Inhibitor Peptide
4. Dtxsid10433062
5. Hishisleuglyglyalalysglnalaglyaspval
6. Bdbm50034686
7. Mfcd00167528
8. Ncgc00167215-01
Molecular Weight | 1189.3 g/mol |
---|---|
Molecular Formula | C50H80N18O16 |
XLogP3 | -9.7 |
Hydrogen Bond Donor Count | 18 |
Hydrogen Bond Acceptor Count | 20 |
Rotatable Bond Count | 39 |
Exact Mass | 1188.59996854 g/mol |
Monoisotopic Mass | 1188.59996854 g/mol |
Topological Polar Surface Area | 547 Ų |
Heavy Atom Count | 84 |
Formal Charge | 0 |
Complexity | 2310 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Global Sales Information
Market Place
ABOUT THIS PAGE
85
PharmaCompass offers a list of Fibrinogen API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fibrinogen manufacturer or Fibrinogen supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fibrinogen manufacturer or Fibrinogen supplier.
PharmaCompass also assists you with knowing the Fibrinogen API Price utilized in the formulation of products. Fibrinogen API Price is not always fixed or binding as the Fibrinogen Price is obtained through a variety of data sources. The Fibrinogen Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Fibrinogen manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fibrinogen, including repackagers and relabelers. The FDA regulates Fibrinogen manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fibrinogen API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Fibrinogen supplier is an individual or a company that provides Fibrinogen active pharmaceutical ingredient (API) or Fibrinogen finished formulations upon request. The Fibrinogen suppliers may include Fibrinogen API manufacturers, exporters, distributors and traders.
click here to find a list of Fibrinogen suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fibrinogen DMF (Drug Master File) is a document detailing the whole manufacturing process of Fibrinogen active pharmaceutical ingredient (API) in detail. Different forms of Fibrinogen DMFs exist exist since differing nations have different regulations, such as Fibrinogen USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Fibrinogen DMF submitted to regulatory agencies in the US is known as a USDMF. Fibrinogen USDMF includes data on Fibrinogen's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fibrinogen USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Fibrinogen suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Fibrinogen Drug Master File in Japan (Fibrinogen JDMF) empowers Fibrinogen API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Fibrinogen JDMF during the approval evaluation for pharmaceutical products. At the time of Fibrinogen JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Fibrinogen suppliers with JDMF on PharmaCompass.
Fibrinogen Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fibrinogen GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fibrinogen GMP manufacturer or Fibrinogen GMP API supplier for your needs.
A Fibrinogen CoA (Certificate of Analysis) is a formal document that attests to Fibrinogen's compliance with Fibrinogen specifications and serves as a tool for batch-level quality control.
Fibrinogen CoA mostly includes findings from lab analyses of a specific batch. For each Fibrinogen CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fibrinogen may be tested according to a variety of international standards, such as European Pharmacopoeia (Fibrinogen EP), Fibrinogen JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fibrinogen USP).